Givaudan SA (OTCMKTS:GVDNY - Get Free Report) declared a dividend on Monday, March 3rd, NASDAQ Dividends reports. Shareholders of record on Tuesday, March 25th will be paid a dividend of 1.5503 per share on Wednesday, April 9th. The ex-dividend date is Tuesday, March 25th. This is a 59.1% increase from Givaudan's previous dividend of $0.97.
Givaudan Trading Up 3.2 %
OTCMKTS GVDNY traded up $2.80 during trading on Friday, reaching $91.10. The company's stock had a trading volume of 16,083 shares, compared to its average volume of 30,681. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.43 and a quick ratio of 0.94. The firm has a fifty day moving average of $87.13 and a 200 day moving average of $93.52. Givaudan has a one year low of $83.36 and a one year high of $110.32.
Wall Street Analysts Forecast Growth
GVDNY has been the topic of a number of research analyst reports. Berenberg Bank upgraded Givaudan from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 14th. Barclays lowered Givaudan from a "hold" rating to a "strong sell" rating in a research note on Friday, November 15th.
Check Out Our Latest Research Report on GVDNY
About Givaudan
(
Get Free Report)
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.
Featured Stories

Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.